期刊文献+

2型糖尿病患者癌抗原125水平及相关影响因素 被引量:3

下载PDF
导出
摘要 目的探讨2型糖尿病患者中癌抗原125(CA125)水平变化及相关影响因素。方法测定352例2型糖尿病患者(糖尿病组)血CA125、空腹血糖、糖化血红蛋白、血脂及体质量指数(BMI)等,通过B超检查排除腹部及妇科肿瘤,并与300例健康对照组进行比较。同时分析糖尿病影响CA125水平的相关因素。结果 352例糖尿病患者影像学检查均正常,糖尿病组与正常对照组CA125水平差异无统计学意义(<0.05),糖尿病组CA125水平变化与年龄、性别、糖尿病病程、BMI、空腹血糖、HbA1c、低密度脂蛋白胆固醇及高密度脂蛋白胆固醇无明显相关性(均>0.05),与甘油三酯和总胆固醇呈弱正相关(=0.167、0.123,均<0.05)。多元逐步回归分析显示甘油三酯和总胆固醇是糖尿病CA125水平增高的主要因素(均<0.05)。结论 2型糖尿病患者的CA125水平与甘油三酯和总胆固醇密切相关,而与血糖控制不佳无相关性。
作者 李宜 王保法
出处 《现代实用医学》 2011年第10期1116-1117,F0003,共3页 Modern Practical Medicine
  • 相关文献

参考文献1

二级参考文献11

  • 1Lucio Gullo.Diabetes and the Risk of Pancreatic Cancer[J].Annals of Oncology.1999(4)
  • 2Locker GY,Hamilton S,Harris J,Jessup JM,Kemeny N,Macdonald JS,Somerfield MR,Hayes DF,Bast RC Jr.ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer[].Journal of Clinical Oncology.2006
  • 3Murray MD,Burton FR,Di Bisceglie AM.Markedly elevated serum CA 19-9 levels in association with a benign biliary stricture due to primary sclerosing cholangitis[].Journal of Clinical Gastroenterology.2007
  • 4Mohan V,Premalatha G,and Pitchumoni CS.Pancreatic diseases and diabetes[].Textbook of diabetes.2003
  • 5Gullo L.Diabetes and the risk of pancreatic cancer[].Annals of Oncology.1999
  • 6Banff G,Ardemagni A,Bravi S,Pacchioni M,Bonini P.Are diabetic metabolic compensation and CA19.9 really correlated[].International Journal of Biological Markers.1996
  • 7U.K. Prospective Diabetes Study Group.U.K.Prospective Diabetes Study 16:Overview of 6 years‘ therapy of typeⅡdiabetes:a progressive disease[].Diabetes.1995
  • 8G(?)ke FJM,G(?)ke B.Optimal control of diabetes mellitus in pancreatitis[].Pancreatitis:Advances in pathobiologydiagnosis and treatment.2005
  • 9Levy P,Milan C,Pignon JP,Baetz A,Bernades P.Mortality factors associated with chronic pancreatitis Unidimensional and multidimensional analysis of a medical-surgical series of 240 patients[].Gastroenterology.1989
  • 10Lowenfels AB,Maisonneuve P.Chronic pancreatitis:precursor of carcinoma?Pancreatitis:Advances in pathobiology, diagnosis and treatment[]..2005

共引文献63

同被引文献19

  • 1张欣,吴令英,李晓江,李洪君,张蓉,刘丽影.盆腔良性肿物伴血清CA_(125)水平升高的临床意义[J].中华妇产科杂志,2005,40(3):178-182. 被引量:65
  • 2周玲,柴华旗.肾病综合征患者血清CA125水平测定[J].苏州大学学报(医学版),2006,26(1):76-77. 被引量:9
  • 3黄继义,江德文,张燕林.癌抗原125检测在慢性肾功能衰竭血液透析患者中的临床意义[J].中华肾脏病杂志,2006,22(9):582-582. 被引量:8
  • 4Oya Uygur-Bayramicli,Resat Dabak,Ekrem Orbay,Can Dolapclo■lu,Mehmet Sargin,Gamze Kilico■lu,Yüksel Güleryüzlü,Alpaslan Mayada■li.Type 2 diabetes mellitus and CA 19-9 levels[J].World Journal of Gastroenterology,2007,13(40):5357-5359. 被引量:64
  • 5Kim SH, Baek CO, Lee KA, et al. Clinical implication of elevated CA 19 9 level and the relationship with glucose control state in patients with type 2 diabetes[J]. Endocrine, 2014,46 (2) : 249.
  • 6Buysschaert M, Sadikot S. Diabetes and cancer: A 2013 synopsis [J]. Diabetes Metab Syndr,2013,7(4) :247.
  • 7Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin--like growth factor-I(IGF. I), IGF binding proteins, their biologic in- teractions, and eolorectal Cancer[J]. J Natl Cancer Inst, 2002,94 (13) :972.
  • 8Federico A,Morgillo F,Tuccillo C,et al. Chronic inflammatin and oxidativestress in human carcinogenesis[J]. Int J Cancer, 2007,21 (11) :2381.
  • 9Rasouli N,Kem PA. Adipocytokines and the metabolic complica- tions of obesity[J]. J Clin Endoerinol Memb, 2008,93 ( 1 lsuppll) : 64.
  • 10Zhang YH, Yin Y, Zhang HZ, et al. Modifiable risk factors for coloncancer[J]. Chinese Journal of Clinical Ontology, 2003, 30 (7) :501.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部